Pricing Log in Create free account

Dyadic International Inc. (DYAI) vs Psyence Biomedical Ltd. (PBM)

Dyadic International Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Dyadic International Inc. and Psyence Biomedical Ltd. are of similar size ($16.8M and $16.5M). Dyadic International Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.2×. Psyence Biomedical Ltd. has the higher net margin (0.00% vs −200.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Dyadic International Inc. leads on 5 and Psyence Biomedical Ltd. on 5.

Valuation

Metric DYAI PBM Biotechnology median
P/E n/m 0.19 8.50
P/S 3.93 n/m 9.71
P/B n/m 0.08 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.82 0.64
EV/Sales 4.03 n/m 9.21
Earnings yield (56.10%) 534.77% (33.15%)
Free cash flow yield (50.30%) (807.70%) (25.50%)

Profitability

Metric DYAI PBM Biotechnology median
Gross margin 16.24% — 65.16%
Operating margin (195.47%) — 0.00%
Net margin (200.46%) 0.00% 0.00%
Free cash flow margin (194.73%) 0.00% 0.00%
Return on equity 522.58% (23.52%) (56.36%)
Return on assets (103.88%) (6.74%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DYAI PBM Biotechnology median
Revenue growth (TTM) (8.05%) — 6.02%
EPS growth (last fiscal year) (15.00%) (138.35%) 30.26%
Revenue growth, 5-year CAGR 14.04% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DYAI PBM Biotechnology median
Debt to equity (2.11) 0.00 0.00
Current ratio 1.65 8.09 4.72
Net debt to EBITDA 0.49 1.20 0.96

Dividend

Metric DYAI PBM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DYAI PBM Biotechnology median
Market cap 16.80m 16.47m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack